Literature DB >> 26713042

Vitamin B12 and cognitive decline.

Serdar Tasdemir1, Umit Hidir Ulas2.   

Abstract

Entities:  

Year:  2015        PMID: 26713042      PMCID: PMC4683909          DOI: 10.4103/0972-2327.169683

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, We have read the study of Tejal Kanhaiya Vedak et al. entitled “Vitamin D as a marker of cognitive decline in elderly Indian population” with great interest.[1] In this study, they aimed to assess the serum levels of 25-hydroxyvitamin D [25(OH)D] and its association with markers of cognitive impairment and homocysteine levels in the elderly Indian population.[1] They reported significantly decreased concentration of 25(OH)D and increased concentration of homocysteine in the serum of patients with dementia when compared to age-matched controls and patients with mild cognitive impairment (MCI) and also reported that an association of serum levels of vitamin D with markers of cognitive decline as well as serum homocysteine levels was observed in patients with dementia and MCI when compared to controls.[1] When we inspected the article in the model of the study, we found that all subjects were evaluated with analysis of blood glucose levels, lipid profile, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), and venereal disease research laboratory test (VDRL), and thyroid profile [triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH)] on fresh serum and in hematology, erythrocyte sedimentation rate (ESR), and complete blood count (CBC) were performed.[1] We noticed that the authors did not consider vitamin B12 levels. The studies showed that low normal concentrations of vitamin B12 might be associated with cognitive impairment[23] Hin et al. evaluated a total of 1,000 individuals aged 75 years and above and they reported that low vitamin B12 concentrations were associated with cognitive impairment in older people in the absence of anemia[4] In a longitudinal cohort study evaluating 1,648 participants, it was shown that low vitamin B12 status was significantly associated with a more rapid cognitive decline during a 10-year period[5] In the deficiency of vitamin B12, there are many possible mechanisms by which brain function is affected. One possibility is homocysteine because low vitamin B12 status is associated with an elevation of the concentration of homocysteine and homocysteine has an effect on the cerebral vasculature.[67] Alternatively, it was concluded that the high prevalence of methylmalonic acid, a marker of vitamin B12 deficiency, in the elderly is associated with lower cognitive function scores and particularly with lower scores of language comprehension and expression.[8] On the other hand, it is stated that vitamin B12 deficiency is accompanied by alterations in the concentrations of cytokines such as epidermal growth factor and tumor necrosis factor-α.[910] By these information from the literature, a few questions arise about evaluating the individuals for study. Did the authors evaluate vitamin B12 in the study group? If yes, this issue should be declared by the authors in our opinion. If not, readers should keep in mind that vitamin B12 deficiency might have an effect on the cognitive function of the brain.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

Review 1.  Nutritional factors in physical and cognitive functions of elderly people.

Authors:  I H Rosenberg; J W Miller
Journal:  Am J Clin Nutr       Date:  1992-06       Impact factor: 7.045

Review 2.  Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia.

Authors:  Rima Obeid; Wolfgang Herrmann
Journal:  FEBS Lett       Date:  2006-05-06       Impact factor: 4.124

Review 3.  The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.

Authors:  Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

4.  Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study.

Authors:  Harold Hin; Robert Clarke; Paul Sherliker; Wale Atoyebi; Kathleen Emmens; Jacqueline Birks; Joern Schneede; Per M Ueland; Ebba Nexo; John Scott; Anne Molloy; Michael Donaghy; Chris Frost; John Grimley Evans
Journal:  Age Ageing       Date:  2006-05-18       Impact factor: 10.668

5.  Low vitamin B-12 status and risk of cognitive decline in older adults.

Authors:  Robert Clarke; Jacqueline Birks; Ebba Nexo; Per M Ueland; Joern Schneede; John Scott; Anne Molloy; John Grimley Evans
Journal:  Am J Clin Nutr       Date:  2007-11       Impact factor: 7.045

6.  Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population.

Authors:  I R Bell; J S Edman; D W Marby; A Satlin; T Dreier; B Liptzin; J O Cole
Journal:  Biol Psychiatry       Date:  1990-01-15       Impact factor: 13.382

Review 7.  Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy.

Authors:  Giuseppe Scalabrino; Daniela Veber; Elena Mutti
Journal:  Brain Res Rev       Date:  2008-05-09

Review 8.  Vitamin B-12 and cognition in the elderly.

Authors:  A David Smith; Helga Refsum
Journal:  Am J Clin Nutr       Date:  2008-12-30       Impact factor: 7.045

9.  Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study.

Authors:  Cherie McCracken; Peter Hudson; Richard Ellis; Andrew McCaddon
Journal:  Am J Clin Nutr       Date:  2006-12       Impact factor: 7.045

10.  Vitamin D as a marker of cognitive decline in elderly Indian population.

Authors:  Tejal Kanhaiya Vedak; Vaishali Ganwir; Arun B Shah; Charles Pinto; Vikram R Lele; Alka Subramanyam; Hina Shah; Sudha Shrikant Deo
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.